duloxetine hydrochloride has been researched along with Peripheral Nerve Diseases in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (8.62) | 29.6817 |
| 2010's | 32 (55.17) | 24.3611 |
| 2020's | 21 (36.21) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, AM; Derman, BA | 1 |
| Hosomi, K; Nakagawa, C; Yokoyama, S | 1 |
| Araldi, D; Bonet, IJM; Green, PG; Levine, JD; Staurengo-Ferrari, L | 1 |
| Asano, H; Hiramoto, S; Kawabata, A; Miyamoto, T; Takegami, M | 1 |
| Feng, S; Mao, M; Wang, J; Wang, X; Zhang, S; Zhou, F | 1 |
| Asama, H; Hashimoto, M; Hikichi, T; Irie, H; Kato, T; Kobashi, R; Konno, N; Nakamura, J; Ohira, H; Okubo, Y; Sato, Y; Sugimoto, M; Suzuki, R; Takagi, T; Takasumi, M | 1 |
| Molassiotis, A; Pei, Z; Wang, M | 1 |
| Aghili, M; Amiri, A; Azadvari, M; Babaei, M; Bayani, R; Darzikolaee, NM; Esmati, E; Farazmand, B; Farhan, F; Ghalehtaki, R; Razavi, SZE; Rezaei, S; Samiei, F | 1 |
| Davis, M; Loprinzi, C | 1 |
| Avallone, A; Bimonte, S; Cardone, C; Cascella, M; Cuomo, A | 1 |
| Bellampalli, S; Boldt, G; Chow, R; Lock, M; Lustberg, M; Novosel, M; Prsic, E; So, OW; Winquist, E; Xiang, J | 1 |
| DiGiacomo, DF; Gibson, AA; Hu, S; Jin, Y; Li, Y; Lustberg, MB; Nepal, MR; Sparreboom, A; Taheri, H; Talebi, Z; Uddin, ME | 1 |
| Aghabozorgi, R; Babaee, M; Hashemi, M; Hesam, M; Rayegani, SM; Zahed, G | 1 |
| Bautista, J; Brown, JS; Curtis, LH; Dworkin, RH; Gewandter, JS; Kleckner, AS; Kleckner, IR; Kolb, N; Marshall, JH; Mohile, SG; Mustian, KM | 1 |
| Cavaletti, G; Islam, B; Lustberg, M; Psimaras, D; Staff, NP; Tamburin, S | 1 |
| Alberti, P; Argyriou, AA; Demichelis, C; Park, SB; Schenone, A; Tamburin, S | 1 |
| Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O | 1 |
| Balayssac, D; Busserolles, J; Courteix, C; Cuménal, M; Kerckhove, N; Selvy, M | 1 |
| Hirayama, Y; Mori, M; Tamura, K; Yoshida, Y | 1 |
| Djordjevic, JD; Jasnic, NI; Micov, AM; Pecikoza, UB; Stepanović-Petrović, RM; Todorović, MB; Tomić, MA; Vuković, MJ | 1 |
| Argyriou, AA; Besora, S; Bruna, J; Calvo, M; Clapés, V; Gil-Gil, M; Izquierdo, C; Jiménez, L; Palmero, R; Pardo, B; Sala, R; Santos, C; Simó, M; Velasco, R | 1 |
| Balayssac, D; Busserolles, J; Farsi, F; Guastella, V; Kerckhove, N; Merle, P; Pereira, B; Pezet, D; Selvy, M | 1 |
| Corradini, L; Kuo, A; Nicholson, JR; Smith, MT | 1 |
| Hosokawa, T; Inagaki, M; Kanbayashi, Y; Ueno, H | 1 |
| Johnson, CE; Kim, PY | 1 |
| Barnes, EH; Battaglini, E; Goldstein, D; Park, SB | 1 |
| Alavi, A; Farshchian, N; Heydarheydari, S; Moradian, N | 1 |
| Bae, K; Jang, CE; Jung, MS; Kim, JR; Kim, M; Lee, JS; Sohn, EH; Yoo, HS | 1 |
| Casteleyn, V; Hahn, K; Siegert, E; Stenzel, W | 1 |
| Adams, EJ; Hu, S; Huang, KM; Loprinzi, CL; Lustberg, MB | 1 |
| Ahles, T; Bressler, LR; Cirrincione, C; Fadul, CE; Fleishman, S; Gilman, PB; Knox, C; Le-Lindqwister, N; Pang, H; Paskett, ED; Shapiro, CL; Smith, EM | 1 |
| Boulton, AJ; Dickenson, AH; Tesfaye, S | 1 |
| Aziz, MT; Good, BL; Lowe, DK | 1 |
| Bak, K; Bleeker, J; Cavaletti, G; Chauhan, C; Dworkin, RH; Gavin, P; Hershman, DL; Lacchetti, C; Lavino, A; Lavoie Smith, EM; Loprinzi, CL; Lustberg, MB; Paice, J; Schneider, B; Smith, ML; Smith, T; Terstriep, S; Wagner-Johnston, N | 1 |
| Irving, G; Malcolm, S; Raskin, J; Risser, RC; Tanenberg, RJ | 1 |
| Chu, SH; Cleeland, CS; Geng, Y; Lee, ES; Lee, YJ; Wang, XS | 1 |
| Egawa-Takata, T; Fujita, M; Isobe, A; Kimura, T; Kobayashi, E; Mabuchi, S; Matsuzaki, S; Otake, A; Sawada, K; Ueda, Y; Yoshino, K | 1 |
| Boehmerle, W; Endres, M; Huehnchen, P | 1 |
| Eckhoff, L; Ewertz, M; Qvortrup, C | 1 |
| Fujimi, A; Hirayama, Y; Horiguchi, H; Ishitani, K; Iyama, S; Kato, J; Kobune, M; Koike, K; Konuma, Y; Kuroda, H; Kusakabe, T; Murase, K; Nagamachi, Y; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R; Terui, T | 1 |
| Ichiba, Y; Kajiume, S; Kiba, T; Morii, N; Mura, T; Nagashima, S; Ogawa, Y; Okada, Y; Takahashi, H; Yamashiro, H | 1 |
| Egashira, N; Higuchi, H; Kaname, T; Kawashiri, T; Shirahama, M; Tsutsumi, K; Ushio, S; Yamamoto, S | 1 |
| Ahles, T; Bressler, LR; Cirrincione, C; Fadul, CE; Fleishman, S; Le-Lindqwister, N; Loprinzi, C; Pang, H; Paskett, ED; Shapiro, CL; Smith, EM; Ye, C | 1 |
| Bhatia, A | 1 |
| Loprinzi, CL; Majithia, N; Smith, TJ | 1 |
| Heller, S; Schuler, U | 1 |
| Eisenach, JC; Hayashida, K | 1 |
| Ferrari, G; Gemignani, F; Giovanelli, M; Macaluso, C; Marbini, A; Vitetta, F | 1 |
| Jefferies, K | 1 |
| Chang, SC; Chen, WS; Chiang, HL; Jiang, JK; Lan, YT; Lin, CC; Lin, JK; Lin, TC; Teng, CJ; Teng, HW; Tzeng, CH; Wang, WS; Yang, SH; Yang, YH; Yen, CC | 1 |
| Ebenezer, GJ; Hauer, P; McArthur, JC; Polydefkis, MJ; Tan, IL | 1 |
| Banno, K; Inoue, N; Ito, S; Kotera, T; Kyoi, T; Nakamura, A; Nogawa, M; Sasagawa, T; Tajima, K; Takahashi, Y; Ueda, M; Yamashita, Y | 1 |
| Iida, H; Matsumoto, S; Miyamoto, M; Takenaka, M; Yamaguchi, S; Yoshimura, N | 1 |
| D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Tran, P; Waninger, A; Wernicke, JF | 1 |
| Wallace, JM | 1 |
| Backonja, MM; Desaiah, D; Farrar, JT; Fishbain, DA; Iyengar, S; Jensen, TS; Kajdasz, DK; McQuay, HJ; Rowbotham, MC; Sang, CN; Ziegler, D | 1 |
| Möller, HJ; Müller, N; Riedel, M; Schennach, R | 1 |
22 review(s) available for duloxetine hydrochloride and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic | 2022 |
Recent advances in managing chemotherapy-induced peripheral neuropathy: A systematic review.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Pain; Pain Management; Peripheral Nervous System Diseases | 2022 |
Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Treatment Outcome | 2022 |
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Quality of Life | 2022 |
Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic | 2023 |
Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Topics: Antineoplastic Agents; Cisplatin; Duloxetine Hydrochloride; Humans; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2019 |
Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Clinical Trials as Topic; Duloxetine Hydrochloride; Epothilones; Humans; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Taxoids; Treatment Outcome; Tubulin Modulators | 2019 |
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials.
Topics: Anticonvulsants; Antidepressive Agents; Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic | 2020 |
Chemotherapy-induced peripheral neuropathy: a review of recent findings.
Topics: Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Vitamin B 12 | 2017 |
[Peripheral nerve involvement in rheumatic diseases].
Topics: Duloxetine Hydrochloride; Humans; Pain Management; Peripheral Nervous System Diseases; Quality of Life; Rheumatic Diseases | 2019 |
Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic | 2019 |
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.
Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2013 |
Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Cyclohexanols; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Milnacipran; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2014 |
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Topics: Adult; Amines; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Comorbidity; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Gels; Humans; Incidence; Ketamine; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Survivors; Thiophenes; Treatment Outcome; United States | 2014 |
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Carbamazepine; Central Nervous System; Cyclohexanols; Duloxetine Hydrochloride; Epothilones; Humans; Neoplasms; Neuralgia; Oxcarbazepine; Peripheral Nervous System Diseases; Pyrazines; Taxoids; Thalidomide; Thiophenes; Venlafaxine Hydrochloride; Vinca Alkaloids | 2015 |
[Chemotherapy-induced neuropathy].
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Peripheral Nervous System Diseases; Thiophenes; Treatment Outcome | 2015 |
Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Topics: Antidepressive Agents; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum Compounds; Quality of Life; Risk Factors; Taxoids; Thiophenes | 2015 |
New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic | 2016 |
[Chemotherapy-induced peripheral neuropathy and neuropathic pain].
Topics: Antineoplastic Agents; Cryotherapy; Duloxetine Hydrochloride; Humans; Neuralgia; Peripheral Nervous System Diseases; Physical Therapy Modalities; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2017 |
Treatment of neuropathic pain.
Topics: Antidepressive Agents, Tricyclic; Duloxetine Hydrochloride; Humans; Neuralgia; Peripheral Nervous System Diseases; Thiophenes | 2010 |
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2007 |
Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Topics: Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Practice Patterns, Physicians'; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2008 |
11 trial(s) available for duloxetine hydrochloride and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical Trial.
Topics: Double-Blind Method; Duloxetine Hydrochloride; Humans; Oxaliplatin; Peripheral Nervous System Diseases | 2023 |
Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Topics: Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases | 2023 |
A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Young Adult | 2018 |
Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Topics: Activities of Daily Living; Analgesics; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation Therapy; Female; Humans; Peripheral Nervous System Diseases; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Republic of Korea; Time Factors; Treatment Outcome | 2018 |
Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Quality of Life; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2013 |
Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pregabalin; Treatment Outcome | 2014 |
Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
Topics: Aged; Antineoplastic Agents; Cross-Over Studies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Pilot Projects; Serotonin and Noradrenaline Reuptake Inhibitors; Vitamin B 12 | 2015 |
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antineoplastic Agents; Colorectal Neoplasms; Duloxetine Hydrochloride; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pain Measurement; Peripheral Nervous System Diseases; Pilot Projects; Severity of Illness Index; Thiophenes | 2012 |
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Adrenergic Uptake Inhibitors; Aged; Analgesics, Non-Narcotic; Diabetic Neuropathies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Norepinephrine; Pain; Palliative Care; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2006 |
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2007 |
25 other study(ies) available for duloxetine hydrochloride and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.
Topics: Adult; Antineoplastic Agents; Cancer Survivors; Duloxetine Hydrochloride; Humans; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
Topics: Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Oxaliplatin; Peripheral Nervous System Diseases; Retrospective Studies | 2022 |
Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Topics: Analgesics; Animals; Antineoplastic Agents; Corticosterone; Duloxetine Hydrochloride; Female; Male; Oxaliplatin; Paclitaxel; Pain Management; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2022 |
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cancer Survivors; Drug Therapy; Duloxetine Hydrochloride; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Risk Factors | 2021 |
Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Duloxetine Hydrochloride; Ganglia, Spinal; Hyperalgesia; Neuralgia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Spinal Cord Dorsal Horn; Substance P; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2022 |
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Topics: Animals; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Mice; Neurotoxicity Syndromes; Oxaliplatin; Peripheral Nervous System Diseases | 2022 |
Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic; Retrospective Studies; United States | 2020 |
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve | 2020 |
Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
Topics: Adult; Antineoplastic Agents; Drugs, Chinese Herbal; Duloxetine Hydrochloride; Humans; Japan; Medical Oncology; Middle Aged; Neoplasms; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Specialization; Surveys and Questionnaires | 2020 |
Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.
Topics: Animals; Antidepressive Agents; Antineoplastic Agents; Behavior, Animal; Brain Stem; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxaliplatin; Pain Measurement; Peripheral Nervous System Diseases; Serotonin; Swimming; Vortioxetine | 2020 |
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cancer Survivors; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Quality of Life; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
Topics: Adult; Amitriptyline; Antineoplastic Agents; Calcium; Cross-Sectional Studies; Duloxetine Hydrochloride; France; Gabapentin; Humans; Magnesium; Male; Middle Aged; Neurotoxicity Syndromes; Oncologists; Peripheral Nervous System Diseases; Practice Patterns, Physicians'; Pregabalin; Surveys and Questionnaires; Vitamins | 2021 |
Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
Topics: Analgesics; Animals; Benzamides; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Glycine Plasma Membrane Transport Proteins; Hyperalgesia; Indomethacin; Male; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2021 |
Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Body Height; Docetaxel; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Quality of Life; Retrospective Studies; ROC Curve; Taxoids | 2017 |
Duloxetine reduces chemotherapy induced peripheral neuropathy.
Topics: Antidepressive Agents; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Pain; Peripheral Nervous System Diseases; Thiophenes | 2013 |
Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
Topics: Adult; Aged; Analgesics; Antineoplastic Agents, Phytogenic; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Thiophenes; Treatment Outcome | 2015 |
[A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Thiophenes; Trastuzumab | 2015 |
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Topics: Administration, Ophthalmic; Analgesics; Animals; Antineoplastic Agents; Axons; Bortezomib; Duloxetine Hydrochloride; Hyperalgesia; Mexiletine; Nerve Degeneration; Neurites; PC12 Cells; Peripheral Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tramadol | 2015 |
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Topics: Adult; Aged; Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Female; Gastrointestinal Neoplasms; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component".
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Thiophenes | 2016 |
Multiplicative interactions to enhance gabapentin to treat neuropathic pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Indans; Injections, Spinal; Ligation; Male; Neurotransmitter Uptake Inhibitors; Nootropic Agents; Pain; Pain Measurement; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Postural Balance; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Spinal Nerves; Thiophenes | 2008 |
Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation.
Topics: Adult; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biopsy; Cornea; Crohn Disease; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Electrophysiology; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Microscopy, Confocal; Middle Aged; Nerve Endings; Nerve Fibers; Peripheral Nervous System Diseases; Sensation Disorders; Sjogren's Syndrome; Skin; Thiophenes; Trigeminal Nerve | 2010 |
Peripheral nerve toxic effects of nitrofurantoin.
Topics: Amines; Analgesics; Anti-Infective Agents, Urinary; Biopsy; Cyclohexanecarboxylic Acids; Cystitis, Interstitial; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Nerve Fibers; Neurologic Examination; Nitrofurantoin; Paresthesia; Perineum; Peripheral Nervous System Diseases; Psoriasis; Skin; Thiophenes; Treatment Outcome; Urinary Tract Infections | 2012 |
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Drug Interactions; Duloxetine Hydrochloride; Etodolac; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mexiletine; Mice; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Thiophenes; Tissue Distribution | 2012 |
Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel.
Topics: Duloxetine Hydrochloride; Humans; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Quality of Life; Thiophenes | 2013 |